DMAC DiaMedica Therapeutics Inc.

NASDAQ

$8.35

DiaMedica Therapeutics Inc. (DMAC) Seasonality

What this stock has historically done over the three months following this point in the calendar year, measured against every other three-month stretch on record.

The three months from October 2

From October, on average

+45.21%

35 matching years

Any three months

+9.91%

1,900 starting points

Difference

+35.3 pts

better than usual

Both lines start at zero on day 0, so the vertical gap reads directly as percentage points better or worse than a random three months. A seasonal line sitting on top of the baseline is a real answer: it says the calendar tells you nothing here. Price history from December 2018 to October 2026.

Between earnings releases

The same study run on the earnings cycle rather than the calendar: the average move from one report to the next, broken out by fiscal quarter, with the announcement gap and the run-up separated out.